Photocure ASA (LON:0IMT)

Market Cap	125.09M
Revenue (ttm)	40.04M
Net Income (ttm)	157.76K
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	792.95
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	966
Average Volume	2,510
Open	63.30
Previous Close	61.80
Day's Range	62.70 - 63.30
52-Week Range	48.00 - 69.80
Beta	0.78
RSI	66.05
Earnings Date	Apr 10, 2026

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreemen...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Employees: 101
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IMT

Financial Performance

Financial numbers in NOK